{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:43:35Z","timestamp":1773272615269,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T00:00:00Z","timestamp":1304294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1756-9966-30-47","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T06:18:30Z","timestamp":1304403510000},"source":"Crossref","is-referenced-by-count":17,"title":["The research on the immuno-modulatory defect of Mesenchymal Stem Cell from Chronic Myeloid Leukemia patients"],"prefix":"10.1186","volume":"30","author":[{"given":"Zhu","family":"Xishan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Guangyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Yuguang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Hongmei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,2]]},"reference":[{"key":"462_CR1","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","volume":"5","author":"DJ Barnes","year":"2006","unstructured":"Barnes DJ, Melo JV: Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle. 2006, 5: 2862-2866. 10.4161\/cc.5.24.3573.","journal-title":"Cell Cycle"},{"key":"462_CR2","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","volume":"109","author":"HG J\u00f8rgensen","year":"2007","unstructured":"J\u00f8rgensen HG, Allan EK, Jordanides NE, Mountford JC, Holyoake TL: Nilotinib exerts equipotent antiproliferative effects to Imatinib and does not induce apoptosis in CD34+CML cells. Blood. 2007, 109: 4016-4019. 10.1182\/blood-2006-11-057521.","journal-title":"Blood"},{"key":"462_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1158\/1078-0432.CCR-05-0429","volume":"12","author":"HG J\u00f8rgensen","year":"2006","unstructured":"J\u00f8rgensen HG, Copland M, Allan EK, Jiang X, Eaves A, Eaves C, Holyoake TL: Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by Imatinib mesylate. Clin Cancer Res. 2006, 12: 626-633. 10.1158\/1078-0432.CCR-05-0429.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"462_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/BJ20070191","volume":"405","author":"C Ries","year":"2007","unstructured":"Ries C, Pitsch T, Mentele R, Zahler S, Egea V, Nagase H, Jochum M: Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1. Biochem J. 2007, 405 (3): 547-58. 10.1042\/BJ20070191.","journal-title":"Biochem J"},{"key":"462_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu Q, Stamenkovic I: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis. Genes Dev. 2000, 14: 163-176.","journal-title":"Genes Dev"},{"key":"462_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1023091214123","volume":"22","author":"R Fridman","year":"2003","unstructured":"Fridman R, Toth M, Chvyrkova I, Meroueh S, Mobashery S: Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev. 2003, 22: 153-166. 10.1023\/A:1023091214123.","journal-title":"Cancer Metastasis Rev"},{"key":"462_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1182\/blood-2006-02-005363","volume":"108","author":"M Stefanidakis","year":"2006","unstructured":"Stefanidakis M, Koivunen E: Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood. 2006, 108: 1441-1450. 10.1182\/blood-2006-02-005363.","journal-title":"Blood"},{"issue":"6","key":"462_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/10245330701384179","volume":"12","author":"Y Baran","year":"2007","unstructured":"Baran Y, Ural AU, Gunduz U: Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells. Hematology. 2007, 12 (6): 497-503. 10.1080\/10245330701384179.","journal-title":"Hematology"},{"issue":"6","key":"462_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/10428190500054491","volume":"46","author":"JG Kim","year":"2005","unstructured":"Kim JG, Sohn SK, Kim DH, Baek JH, Lee NY, Suh JS: Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma. 2005, 46 (6): 885-91. 10.1080\/10428190500054491.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"462_CR10","first-page":"681","volume":"23","author":"Y Kaneta","year":"2003","unstructured":"Kaneta Y, Kagami Y, Tsunoda T, Ohno R, Nakamura Y, Katagiri T: Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray. Int J Oncol. 2003, 23 (3): 681-91.","journal-title":"Int J Oncol"},{"issue":"6","key":"462_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/10428190290026358","volume":"43","author":"H Bruchova","year":"2002","unstructured":"Bruchova H, Borovanova T, Klamova H, Brdicka R: Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk Lymphoma. 2002, 43 (6): 1289-95. 10.1080\/10428190290026358.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"462_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/sj.leu.2402486","volume":"16","author":"A Janowska-Wieczorek","year":"2002","unstructured":"Janowska-Wieczorek A, Majka M, Marquez-Curtis L, Wertheim JA, Turner AR, Ratajczak MZ: Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia. 2002, 16 (6): 1160-6. 10.1038\/sj.leu.2402486.","journal-title":"Leukemia"},{"issue":"4","key":"462_CR13","first-page":"1094","volume":"7","author":"RK Narla","year":"2001","unstructured":"Narla RK, Dong Y, Klis D, Uckun FM: Bis(4,7-dimethyl-1, 10-phenanthroline) sulfatooxovanadium(I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity. Clin Cancer Res. 2001, 7 (4): 1094-101.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"462_CR14","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.leu.2404990","volume":"22","author":"X Sun","year":"2008","unstructured":"Sun X, Li Y, Yu W, Wang B, Tao Y, Dai Z: MT1-MMP as a downstream target of BCR-ABL\/ABL interactor 1 signaling: polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration. Leukemia. 2008, 22 (5): 1053-6. 10.1038\/sj.leu.2404990.","journal-title":"Leukemia"},{"issue":"5","key":"462_CR15","first-page":"1115","volume":"5","author":"C Ries","year":"1999","unstructured":"Ries C, Loher F, Zang C, Ismair MG, Petrides PE: Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res. 1999, 5 (5): 1115-24.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"462_CR16","first-page":"681","volume":"23","author":"Y Kaneta","year":"2003","unstructured":"Kaneta Y, Kagami Y, Tsunoda T, Ohno R, Nakamura Y, Katagiri T: Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray. Int J Oncol. 2003, 23 (3): 681-91.","journal-title":"Int J Oncol"},{"issue":"11","key":"462_CR17","first-page":"344","volume":"5","author":"Yoon Sang-Oh","year":"2006","unstructured":"Sang-Oh Yoon, Sejeong Shin, Ho-Jae Lee: Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinosito 3 kinase\/Akt dependent matrix metalloproteinase-9 expression. Mol Cancer Ther. 2006, 5 (11): 344-349.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"462_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2008.03.025","volume":"267","author":"P Anand","year":"2008","unstructured":"Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB: Curcumin and cancer: an \"old-age\" disease with an \"age-old\" solution. Cancer Lett. 2008, 267 (1): 133-64. 10.1016\/j.canlet.2008.03.025.","journal-title":"Cancer Lett"},{"issue":"7","key":"462_CR19","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1182\/blood-2004-07-2514","volume":"105","author":"Baijun Fang","year":"2005","unstructured":"Fang Baijun, Zheng Chunmei, Liao Lianming, Shi Mingxia, Yang Shaoguang, Zhao RCH: Identification of Human Chronic Myelogenous Leukemia Progenitor Cells with Hemangioblastic Characteristics. Blood. 2005, 105 (7): 2733-40. 10.1182\/blood-2004-07-2514.","journal-title":"Blood"},{"key":"462_CR20","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1182\/blood.V98.9.2615","volume":"98","author":"M Reyes","year":"2001","unstructured":"Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001, 98: 2615-25. 10.1182\/blood.V98.9.2615.","journal-title":"Blood"},{"key":"462_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0301-472X(03)00087-0","volume":"31","author":"H Guo","year":"2003","unstructured":"Guo H, Fang B, Zhao RC: Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cells. Exp Hematol. 2003, 31: 650-613. 10.1016\/S0301-472X(03)00087-0.","journal-title":"Exp Hematol"},{"key":"462_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1189\/jlb.0904498","volume":"78","author":"Lu Yunbiao","year":"2005","unstructured":"Yunbiao Lu, Larry M: Wahl. Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase\/Akt\/IKK\/NF-\u03baB pathway. J Leuk Bio. 2005, 78: 259-65. 10.1189\/jlb.0904498.","journal-title":"J Leuk Bio"},{"key":"462_CR23","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1074\/jbc.M306976200","volume":"279","author":"JA Gustin","year":"2004","unstructured":"Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB: Cell type-specific expression of the I\u03baB kinases determines the significance of phosphati-dylinositol 3-kinase\/Akt signaling to NF-\u03baB activation. J Biol Chem. 2004, 279: 1615-1620.","journal-title":"J Biol Chem"},{"issue":"3","key":"462_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/nnm.10.8","volume":"5","author":"IE Palam\u00e0","year":"2010","unstructured":"Palam\u00e0 IE, Leporatti S, de Luca E, Di Renzo N, Maffia M, Gambacorti-Passerini C, Rinaldi R, Gigli G, Cingolani R, Coluccia AM: Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL+ leukemia stem cells. Nanomedicine (Lond). 2010, 5 (3): 419-31. 10.2217\/nnm.10.8.","journal-title":"Nanomedicine (Lond)"},{"issue":"9 Suppl","key":"462_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbmt.2008.06.006","volume":"14","author":"C Karanes","year":"2008","unstructured":"Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, Porter DL, Uberti JP, King RJ, Confer DL: Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008, 14 (9 Suppl): 8-15. 9","journal-title":"Biol Blood Marrow Transplant"},{"key":"462_CR26","first-page":"1","volume":"29","author":"MG Martin","year":"2008","unstructured":"Martin MG, Dipersio JF, Uy GL: Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leuk Lymphoma. 2008, 29: 1-10.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"462_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ncponc1276","volume":"6","author":"G Martinelli","year":"2009","unstructured":"Martinelli G, Soverini S, Iacobucci I, Baccarani M: Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapy. Nat Clin Pract Oncol. 2009, 6 (2): 68-9.","journal-title":"Nat Clin Pract Oncol"},{"key":"462_CR28","first-page":"436","volume":"34","author":"H Catriona","year":"2008","unstructured":"Catriona H, Jamieson Y: Chronic myeloid leukemia stem cell. Hematology Am Soc Hematol Educ Program. 2008, 34: 436-42.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"462_CR29","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1182\/blood-2003-09-3033","volume":"104","author":"SD Pelletier","year":"2004","unstructured":"Pelletier SD, Hong DS, Hu Y, Liu Y, Li S: Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR\/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice. Blood. 2004, 104: 2163-2171. 10.1182\/blood-2003-09-3033.","journal-title":"Blood"},{"key":"462_CR30","first-page":"139","volume":"85","author":"GA Martin-Henao","year":"2000","unstructured":"Martin-Henao GA, Quiroga R, Sureda A, Gonz\u00e1lez JR, Moreno V, Garc\u00eda J: L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. Haematologica. 2000, 85: 139-146.","journal-title":"Haematologica"},{"issue":"11","key":"462_CR31","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1182\/blood.V99.11.4122","volume":"99","author":"JA Wertheim","year":"2002","unstructured":"Wertheim JA, Forsythe K, Druker BJ, Hammer D, Boettiger D, Pear WS: BCR-ABL-induced adhesion defects are tyrosine kinase-independent. Blood. 2002, 99 (11): 4122-4130. 10.1182\/blood.V99.11.4122.","journal-title":"Blood"},{"key":"462_CR32","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1038\/sj.onc.1205684","volume":"21","author":"Emilio Fiore","year":"2002","unstructured":"Fiore Emilio, Fusco Carlo, Romero Pedro: Matrix metalloproteinase 9 (MMP-\/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene. 2002, 21: 5213-5223. 10.1038\/sj.onc.1205684.","journal-title":"Oncogene"},{"key":"462_CR33","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1182\/blood-2006-02-005363","volume":"108","author":"E Darai","year":"2006","unstructured":"Darai E, Stefanidakis M, Koivunen E: Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood. 2006, 108: 1441-1450. 10.1182\/blood-2006-02-005363.","journal-title":"Blood"},{"key":"462_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1034\/j.1600-0609.2003.00064.x","volume":"10","author":"S Molica","year":"2003","unstructured":"Molica S, Vitelli G, Levato D, Giannarelli D, Vacca A, Cuneo A, Cavazzini F, Squillace R, Mirabelli R, Digiesi G: Increased serum levels of matrix metalloproteinase-9 predict clinical utcome of patients with early B-cell chronic lymphocytic leukemia. European Journal of Haematology. 2003, 10: 373-378.","journal-title":"European Journal of Haematology"},{"key":"462_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1365-2141.2004.04877.x","volume":"125","author":"AS Kamiguti","year":"2004","unstructured":"Kamiguti AS, Lee ES, Till KJ, Harris RJ, Glenn MA, Lin K, Chen HJ, Zuzel M, Cawley JC: The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia. Br J Haematol. 2004, 125: 128-140. 10.1111\/j.1365-2141.2004.04877.x.","journal-title":"Br J Haematol"},{"issue":"7","key":"462_CR36","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.febslet.2007.02.048","volume":"581","author":"GM M\u00f8ller","year":"2007","unstructured":"M\u00f8ller GM, Frost V, Melo JV, Chantry A: Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia. FEBS Lett. 2007, 581 (7): 1329-34. 10.1016\/j.febslet.2007.02.048.","journal-title":"FEBS Lett"},{"issue":"10","key":"462_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.embor.7400501","volume":"6","author":"A Atfi","year":"2005","unstructured":"Atfi A, Ab\u00e9cassis L, Bourgeade MF: Bcr-Abl activates the AKT\/Fox O3 signalling pathway to restrict transforming growth factor-beta-mediated cytostatic signals. EMBO Rep. 2005, 6 (10): 985-91. 10.1038\/sj.embor.7400501.","journal-title":"EMBO Rep"},{"issue":"7281","key":"462_CR38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, Nakao S, Motoyama N, Hirao A: TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010, 463 (7281): 676-80. 10.1038\/nature08734.","journal-title":"Nature"},{"issue":"7","key":"462_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/08820130802349940","volume":"37","author":"ZG Zhao","year":"2008","unstructured":"Zhao ZG, Li WM, Chen ZC, You Y, Zou P: Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia. Immunol Invest. 2008, 37 (7): 726-39. 10.1080\/08820130802349940.","journal-title":"Immunol Invest"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-30-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-30-47\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-30-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T13:45:38Z","timestamp":1637588738000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-30-47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-30-47","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,2]]},"article-number":"47"}}